<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35196382</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>19</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1945-7197</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>107</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>17</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of clinical endocrinology and metabolism</Title>
          <ISOAbbreviation>J Clin Endocrinol Metab</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Insulin Pump-related Inpatient Admissions in a National Sample of Youth With Type 1 Diabetes.</ArticleTitle>
        <Pagination>
          <StartPage>e2381</StartPage>
          <EndPage>e2387</EndPage>
          <MedlinePgn>e2381-e2387</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1210/clinem/dgac047</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Insulin pump use in type 1 diabetes management has significantly increased in recent years, but we have few data on its impact on inpatient admissions for acute diabetes complications.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We used the 2006, 2009, 2012, and 2019 Kids' Inpatient Database to identify all-cause type 1 diabetes hospital admissions in those with and without documented insulin pump use and insulin pump failure. We described differences in (1) prevalence of acute diabetes complications, (2) severity of illness during hospitalization and disposition after discharge, and (3) length of stay (LOS) and inpatient costs.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 228 474 all-cause admissions. Insulin pump use was documented in 7% of admissions, of which 20% were due to pump failure. The prevalence of diabetic ketoacidosis (DKA) was 47% in pump nonusers, 39% in pump users, and 60% in those with pump failure. Admissions for hyperglycemia without DKA, hypoglycemia, sepsis, and soft tissue infections were rare and similar across all groups. Admissions with pump failure had a higher proportion of admissions classified as major severity of illness (14.7%) but had the lowest LOS (1.60 days, 95% CI 1.55-1.65) and healthcare costs ($13 078, 95% CI $12 549-$13 608).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Despite the increased prevalence of insulin pump in the United States, a minority of pediatric admissions documented insulin pump use, which may represent undercoding. DKA admission rates were lower among insulin pump users compared to pump nonusers. Improved accuracy in coding practices and other approaches to identify insulin pump users in administrative data are needed, as are interventions to mitigate risk for DKA.</AbstractText>
          <CopyrightInformation>© The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Everett</LastName>
            <ForeName>Estelle M</ForeName>
            <Initials>EM</Initials>
            <Identifier Source="ORCID">0000-0002-7468-296X</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Endocrinology, Diabetes, &amp; Metabolism, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of General Internal Medicine &amp; Health Services Research, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Veteran Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Copeland</LastName>
            <ForeName>Timothy P</ForeName>
            <Initials>TP</Initials>
            <Identifier Source="ORCID">0000-0002-3813-3576</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Moin</LastName>
            <ForeName>Tannaz</ForeName>
            <Initials>T</Initials>
            <Identifier Source="ORCID">0000-0002-5035-6641</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Endocrinology, Diabetes, &amp; Metabolism, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of General Internal Medicine &amp; Health Services Research, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Veteran Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>HSR&amp;D Center for the Study of Healthcare Innovation, Implementation &amp; Policy, Veteran Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wisk</LastName>
            <ForeName>Lauren E</ForeName>
            <Initials>LE</Initials>
            <Identifier Source="ORCID">0000-0003-2932-4140</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of General Internal Medicine &amp; Health Services Research, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>L40 DK129996</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>K01DK116932</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01DK124503</GrantID>
            <Acronym>GF</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>U18DP006535</GrantID>
            <Acronym>CC</Acronym>
            <Agency>CDC HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>QUE20-028</GrantID>
            <Acronym>VA</Acronym>
            <Agency>VA</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>SDM-2018C2-13543</GrantID>
            <Acronym>PCORI</Acronym>
            <Agency>Patient-Centered Outcomes Research Institute</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Clin Endocrinol Metab</MedlineTA>
        <NlmUniqueID>0375362</NlmUniqueID>
        <ISSNLinking>0021-972X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007328">Insulin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D061385">Insulins</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016883" MajorTopicYN="Y">Diabetic Ketoacidosis</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007297" MajorTopicYN="N">Inpatients</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007332" MajorTopicYN="N">Insulin Infusion Systems</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D061385" MajorTopicYN="Y">Insulins</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">diabetic ketoacidosis</Keyword>
        <Keyword MajorTopicYN="N">inpatient admissions</Keyword>
        <Keyword MajorTopicYN="N">insulin pump</Keyword>
        <Keyword MajorTopicYN="N">type 1 diabetes</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2023</Year>
          <Month>2</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>23</Day>
          <Hour>17</Hour>
          <Minute>12</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35196382</ArticleId>
        <ArticleId IdType="pmc">PMC9113825</ArticleId>
        <ArticleId IdType="doi">10.1210/clinem/dgac047</ArticleId>
        <ArticleId IdType="pii">6535117</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
Schmitt J, Scott ML. Insulin degludec in adolescents with type 1 diabetes: is newer better? A retrospective self-control case series in adolescents with a history of diabetic ketoacidosis. Horm Res Paediatr. 2019;92(3):179-185.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31865335</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Thalange N, Deeb L, Klingensmith G, et al. . 
The rate of hyperglycemia and ketosis with insulin degludec-based treatment compared with insulin detemir in pediatric patients with type 1 diabetes: an analysis of data from two randomized trials. Pediatr Diabetes. 2019;20(3):314-320.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6849556</ArticleId>
            <ArticleId IdType="pubmed">30666772</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Guilhem I, Leguerrier AM, Lecordier F, Poirier JY, Maugendre D. Technical risks with subcutaneous insulin infusion. Diabetes Metab. 2006;32(3):279-284.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16799407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Berg AK, Thorsen SU, Thyssen JP, Zachariae C, Keiding H, Svensson J. Cost of treating skin problems in patients with diabetes who use insulin pumps and/or glucose sensors. Diabetes Technol Ther. 2020;22(9):658-665</Citation>
        </Reference>
        <Reference>
          <Citation>
Van Den Boom L, Karges B, Auzanneau M, et al. . 
Temporal trends and contemporary use of insulin pump therapy and glucose monitoring among children, adolescents, and adults with type 1 diabetes between 1995 and 2017. Diabetes Care. 2019;42(11):2050-2056.</Citation>
        </Reference>
        <Reference>
          <Citation>
Everett EM, Copeland TP, Moin T, Wisk LE. National trends in pediatric admissions for diabetic ketoacidosis, 2006-2016. J Clin Endocrinol Metab. 2021;106(8):2343-2354.</Citation>
        </Reference>
        <Reference>
          <Citation>
HCUP-KID overview. ProMED-mail website. Accessed May 29, 2020. https://www.hcup-us.ahrq.gov/kidoverview.jsp</Citation>
        </Reference>
        <Reference>
          <Citation>
Everett EM, Copeland TP, Moin T, Wisk LE.Supplemental data for: Insulin pump related admissions in a national sample of youth with type 1 diabetes. FigShare. Deposited February 14, 2022. Doi: 10.6084/m9.figshare.16869107</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.6084/m9.figshare.16869107</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Averill AF, Goldfield N, Hughes JS, et al. . 
All Patient Refined Diagnosis Related Groups (APR-DRGs) methodology overview. 3M Health Information Systems. 2003. ProMED-mail website. Accessed September 1, 2021. https://www.hcup-us.ahrq.gov/db/nation/nis/APR-DRGsV20MethodologyOverviewandBibliography.pdf</Citation>
        </Reference>
        <Reference>
          <Citation>
US Bureau of Labor Statistics. Consumer Price Index. 2021. ProMED-mail website. Accessed August 25, 2021. https://www.bls.gov/cpi/</Citation>
        </Reference>
        <Reference>
          <Citation>
Lipman TH, Willi SM, Lai CW, Smith JA, Patil O, Hawkes CP. Insulin pump use in children with type 1 diabetes: over a decade of disparities. J Pediatr Nurs. 2020;55:110-115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32889433</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Willi SM, Miller KM, DiMeglio LA, et al. . 
Racial-ethnic disparities in management and outcomes among children with type 1 diabetes. Pediatrics. 2015;135(3):424-434.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4533245</ArticleId>
            <ArticleId IdType="pubmed">25687140</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
O’Reilly JE, Jeyam A, Caparrotta TM, et al. . 
Rising rates and widening socioeconomic disparities in diabetic ketoacidosis in type 1 diabetes in Scotland: a nationwide retrospective cohort observational study. Diabetes Care. 2021:44(9):2010-2017.</Citation>
        </Reference>
        <Reference>
          <Citation>
Paris CA, Imperatore G, Klingensmith G, et al. . 
Predictors of insulin regimens and impact on outcomes in youth with type 1 diabetes: the SEARCH for Diabetes in Youth Study
J Pediatr.
2009;155(2):183-189.e1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19394043</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
O’Connor MR, Carlin K, Coker T, et al. . 
Disparities in insulin pump therapy persist in youth with type 1 diabetes despite rising overall pump use rates. J Pediatr Nurs. 2019;44:16-21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30581163</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Everett E, Copeland T, Moin T, Wisk L. National trends in pediatric admissions for diabetic ketoacidosis, 2006-2016. J Clin Endocrinol Metab. 2021;106(8):2343-2354.</Citation>
        </Reference>
        <Reference>
          <Citation>
Benoit SR, Zhang Y, Geiss LS, Gregg EW, Albright A. Trends in diabetic ketoacidosis hospitalizations and in-hospital mortality—United States, 2000–2014. MMWR Morb Mortal Wkly Rep. 2018;67(12):362-365.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5877353</ArticleId>
            <ArticleId IdType="pubmed">29596400</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Desai D, Mehta D, Mathias P, Menon G, Schubart UK. Health care utilization and burden of diabetic ketoacidosis in the U.S. over the past decade: a nationwide analysis. Diabetes Care. 2018;41(8):1631-1638.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29773640</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Everett E, Mathioudakis N. Association of socioeconomic status and DKA readmission in adults with type 1 diabetes: analysis of the US National Readmission Database. BMJ Open Diab Res Care. 2019;7:e000621.</Citation>
        </Reference>
        <Reference>
          <Citation>
Everett E, Mathioudakis N. Association of area deprivation and diabetic ketoacidosis readmissions: comparative risk analysis of adults vs children with type 1 diabetes. J Clin Endocrinol Metab. 2019;104:3473-3480.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6599429</ArticleId>
            <ArticleId IdType="pubmed">31220288</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Karges B, Schwandt A, Heidtmann B, et al. . 
Association of insulin pump therapy vs insulin injection therapy with severe hypoglycemia, ketoacidosis, and glycemic control among children, adolescents, and young adults with type 1 diabetes. JAMA. 2017;318(14):1358-1366.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5818842</ArticleId>
            <ArticleId IdType="pubmed">29049584</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hoshina S, Andersen GS, Jørgensen ME, Ridderstråle M, Vistisen D, Andersen HU. Treatment modality-dependent risk of diabetic ketoacidosis in patients with type 1 diabetes: Danish Adult Diabetes Database Study. Diabetes Technol Ther. 2018;20(3):229-234.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29437465</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Pala L, Dicembrini I, Mannucci E. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials. Acta Diabetol. 2019;56(9):973-980.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30945047</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ross P, Gray A, Milburn J, et al. . 
Insulin pump-associated adverse events are common, but not associated with glycemic control, socio-economic status, or pump/infusion set type. Acta Diabetol. 2016;53(6):991-998.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27585938</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Korbel L, Easterling RS, Punja N, Spencer JD. The burden of common infections in children and adolescents with diabetes mellitus: a Pediatric Health Information System study. Pediatr Diabetes. 2018;19(3):512-519.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29094435</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Zhang E, Cao Z. Tissue response to subcutaneous infusion catheter. J Diabetes Sci Technol. 2019;14(2):226-232.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7196874</ArticleId>
            <ArticleId IdType="pubmed">30931603</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Berg AK, Nørgaard K, Thyssen JP, et al. . 
Skin problems associated with insulin pumps and sensors in adults with type 1 diabetes: a cross-sectional study. Diabetes Technol Ther. 2018;20(7):475-482.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29893593</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ghosh AK, Geisler BP, Ibrahim S. Racial/ethnic and socioeconomic variations in hospital length of stay: a state-based analysis. Medicine (Baltim). 2021;100(20):e25976.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
